Andrew J. Laster, MD, FACR, CCD
EULAR has for the first time updated its 2007 recommendations for the management of hand osteoarthritis, including a new warning against treatment with conventional or biological disease-modifying antirheumatic drugs. The update was published in the Annals of the Rheumatic Diseases.
“For a long time, hand OA was a ‘forgotten disease’, resulting in a paucity of clinical trials to guide recommendations, and therefore many of the propositions of previous recommendations were based mainly on expert opinion,” Margreet Kloppenburg, MD, PhD, of the Leiden University Medical Center in the Netherlands, and colleagues wrote. “However, in recent years, hand OA has attracted more attention, and new data have become available on several pharmacological and non-pharmacological treatments, including but not limited to: self-management, application of thumb base orthoses, topical [NSAIDs] oral corticosteroids, various intra-articular therapies and treatment with conventional synthetic and biological [DMARDs] for example, hydroxychloroquine and [TNF] inhibitors.”
This activity is supported by an educational grant from Pfizer, Inc.
Heart in Diabetes
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.